Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China · Delayed Price · Currency is CNY 10.01
+0.14 (1.42%)
Sep 1, 2026, 3:00 PM CST
SHA:603108 Market Cap
SHA:603108 has a market cap or net worth of 5.96 billion as of August 31, 2026. Its market cap has decreased by -43.82% in one year.
Market Cap
5.96B
Enterprise Value
12.49B
Revenue
6.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.01
ChartMarket Cap Chart
Since May 27, 2015, SHA:603108's market cap has increased from 2.30B to 5.96B, an increase of 158.59%. That is a compound annual growth rate of 8.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 5.96B | -33.98% |
| Dec 31, 2025 | 9.02B | -5.40% |
| Dec 31, 2024 | 9.54B | -19.99% |
| Dec 29, 2023 | 11.92B | 103.50% |
| Dec 30, 2022 | 5.86B | -24.61% |
| Dec 31, 2021 | 7.77B | 19.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dian Diagnostics Group | 11.28B |
| Amoy Diagnostics | 6.85B |
| Beijing Strong Biotechnologies,Inc. | 6.85B |
| Maccura Biotechnology Co.Ltd | 5.64B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.26B |
| Guangdong Hybribio Biotech | 3.80B |
| Thalys Medical Technology Group | 3.66B |